Pethidine can provide short-term relief of acute pain, but it is not effective for everyone. During labour, intramuscular or intravenous pethidine sedates women, but may not give them adequate analgesia. Pethidine and its active metabolite, norpethidine, can have adverse effects on the neonate as well as the mother, especially if repeated doses are given during labour. There is little evidence to show that other drugs have greater efficacy than pethidine, so epidural analgesia may be a more effective option.
Introduction
Many women prefer to experience birth actively and as naturally 
Efficacy of pethidine in labour
Early studies reporting that pethidine had good analgesic effects in labour were unfortunately flawed because efficacy was evaluated by an independent observer rather than the patient. If the patients were interviewed it was 24 hours post-delivery. 3 A double-blind randomised controlled trial compared intravenous pethidine with placebo in 84 women during labour. Pethidine provided effective pain relief in only 23.8%
of patients compared to 7% of those given placebo. Although this difference is significant (p < 0.05), there was no difference between the median or mean visual analogue pain scores in the pethidine and placebo groups. Pethidine significantly increased the sedation scores, dizziness, nausea and vomiting. 4 
Comparison with other analgesics
In a randomised controlled trial involving 20 patients in labour, pethidine (up to 1.5 mg/kg) and morphine (up to 0.15 mg/kg) given intravenously produced no significant change in pain scores over time with three doses. Following treatment with opioids 15 of the patients requested an epidural. Nausea was more common with pethidine (6/10) than with morphine (1/10).
Patients receiving pethidine were calmer and more euphoric, but both drugs caused similar significant sedation (mean sedation scores 8/10 after three doses). The patients were therefore all significantly sedated and fell asleep during labour, but were awakened by pain during contractions. The researchers concluded that labour pain was not sensitive to systemically administered pethidine or morphine and that it was unethical to treat requests for pain relief by giving sedation. 5 Pethidine has also been compared with intravenous fentanyl 6 , remifentanil 7 and tramadol in randomised controlled trials.
Fentanyl given as an intermittent intravenous infusion was equianalgesic to pethidine, but caused less nausea, vomiting and sedation. Remifentanil given as patient-controlled analgesia produced significantly lower pain scores than pethidine. However, the study was terminated early due to low Apgar scores in the pethidine group. In one study tramadol 100 mg intramuscularly had no greater efficacy than pethidine 75 mg. 8 Tramadol has its own safety issues.
A Cochrane review of the available studies has concluded that there is not enough evidence to evaluate the comparative efficacy and safety of the various opioids used for analgesia in labour. 9 Despite antenatal ambivalence about a specific analgesic choice, 65% of nulliparous women in one Australian tertiary unit chose epidural analgesia. Nearly 60% of women given intramuscular opioid 'crossed over' to epidural analgesia, confirming the inadequacy of systemically administered opioids. 10 
Pharmacology
There are pharmacokinetic reasons why systemically administered opioids are ineffective in controlling the pain of labour. Following injection into the gluteal muscle, plasma concentrations of pethidine are significantly lower than after intravenous administration or injection into the deltoid muscle.
This suggests that drug absorption from the gluteal muscles
